Australia markets closed

Nxera Pharma Co., Ltd. (SOLTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
9.82+0.04 (+0.37%)
At close: 09:30AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 860.99M
Enterprise value 1.03B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.83
Price/book (mrq)2.07
Enterprise value/revenue 0.07
Enterprise value/EBITDA 0.34

Trading information

Stock price history

Beta (5Y monthly) 0.60
52-week change 3-53.43%
S&P500 52-week change 326.27%
52-week high 322.78
52-week low 38.56
50-day moving average 310.20
200-day moving average 310.15

Share statistics

Avg vol (3-month) 3925
Avg vol (10-day) 340
Shares outstanding 589.45M
Implied shares outstanding 690.94M
Float 866.49M
% held by insiders 19.63%
% held by institutions 142.43%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 427 Mar 2015
Last split factor 2100:1
Last split date 327 Mar 2013

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -55.20%
Operating margin (ttm)-66.71%

Management effectiveness

Return on assets (ttm)-5.73%
Return on equity (ttm)-14.62%

Income statement

Revenue (ttm)16.43B
Revenue per share (ttm)194.72
Quarterly revenue growth (yoy)389.00%
Gross profit (ttm)N/A
EBITDA -8.39B
Net income avi to common (ttm)-9.07B
Diluted EPS (ttm)-0.69
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)46.51B
Total cash per share (mrq)520.03
Total debt (mrq)72.47B
Total debt/equity (mrq)110.00%
Current ratio (mrq)4.17
Book value per share (mrq)736.60

Cash flow statement

Operating cash flow (ttm)-6.32B
Levered free cash flow (ttm)-12.28B